Macquarie Group Limited 13D and 13G filings for Vanda Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 1:34 pm Sale | 2022-12-30 | 13G | Vanda Pharmaceuticals Inc. VNDA | Macquarie Group Limited | 1,323,547 2.340% | -1,589,924 (-54.57%) | Filing |
| 2022-02-14 11:15 am Sale | 2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | Macquarie Group Limited | 2,913,471 5.230% | -278,563 (-8.73%) | Filing |
| 2021-02-12 08:25 am Purchase | 2020-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | Macquarie Group Limited | 3,192,034 5.830% | 94,212 (+3.04%) | Filing |